Related Experiment Video
Updated: Nov 20, 2025

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
Framework for the evaluation of new tests for tuberculosis infection
Yohhei Hamada1,2, Saskia den Boon3, Daniela Maria Cirillo4
1Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan y.hamada@ucl.ac.uk.
Accelerating tuberculosis (TB) preventive treatment (TPT) requires simpler TB infection tests. This framework guides the evaluation of new immunodiagnostic tests to speed up adoption and scale-up.
Area of Science:
- Immunology
- Public Health
- Infectious Diseases
Background:
- Global targets necessitate accelerated scale-up of tuberculosis (TB) preventive treatment (TPT).
- Current TB infection testing methods face operational challenges hindering TPT scale-up.
- Development of simpler diagnostic tests is crucial for widespread TB infection screening.
Purpose of the Study:
- To present a standardized framework for evaluating novel immunodiagnostic tests for TB infection.
- To facilitate the adoption of new TB infection tests into global and national health policies.
- To guide manufacturers, researchers, and regulators in test evaluation and scale-up.
Main Methods:
- Development of a comprehensive evaluation framework for new TB infection tests.
- Guidance on study design, population selection, reference standards, and sample size calculation.
- Consideration of technical aspects including safety, cost, and operational characteristics.
Main Results:
- A structured approach for evaluating new TB infection immunodiagnostic tests is proposed.
- The framework addresses key principles for standardized assessment.
- Guidance is provided for various stakeholders involved in TB diagnostics.
Conclusions:
- A standardized evaluation framework is essential to accelerate the adoption and scale-up of new TB infection tests.
- Addressing operational and technical challenges is key to improving TPT delivery.
- This framework supports the global strategy for TB research and innovation.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Sputum Studies II: Culture and Sensitivity
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...

